Allarity Therapeutics (ALLR) Preferred Dividend Payments (2022 - 2024)
Allarity Therapeutics' (ALLR) quarterly Preferred Dividend Payments came in at $71000.0 in Q2 2024, down 99.03% YoY from $7.3 million in Q3 2023, and down 68.86% on a QoQ basis from $228000.0 in Q1 2024.
Allarity Therapeutics (ALLR) Preferred Dividend Payments (2022 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 3 years of Preferred Dividend Payments data on file, last reported at $71000.0 in Q2 2024.
- Quarterly Preferred Dividend Payments fell 99.03% year-over-year to $71000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $71000.0 (down 99.06% YoY) and the FY2024 annual result came in at $299000.0, down 96.44% from the prior year.
- Preferred Dividend Payments fell to $71000.0 in Q2 2024, from $228000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $7.3 million in Q2 2023 to a low of $4000.0 in Q1 2023.
- A 3-year average of $1.7 million and a median of $1.4 million in 2022 frame the typical range for Preferred Dividend Payments.
- Annual changes were most pronounced in 2023 — Preferred Dividend Payments sank 99.75% — and 2024, when it soared 5600.0%.
- Tracing ALLR's Preferred Dividend Payments over 3 years: stood at $1.6 million in 2022, then soared by 342.71% to $7.3 million in 2023, then sank by 99.03% to $71000.0 in 2024.
- The last three Preferred Dividend Payments figures came in at $71000.0 (Q2 2024), $228000.0 (Q1 2024), and $7.3 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Allarity Therapeutics | 23.23 Mn | 23.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 71,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Jun 30, 2023 | 7.29 Mn |
| Mar 31, 2023 | 4,000.00 |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.57 Mn |